ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China flag China · Delayed Price · Currency is CNY
14.21
-0.30 (-2.07%)
Nov 13, 2026, 3:00 PM CST

ChengDu ShengNuo Biotec Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
201.5157.9250.0270.3464.4861.25
Depreciation & Amortization
56.5456.5434.5627.6524.6918.26
Other Amortization
1.471.471.191.491.270.49
Loss (Gain) From Sale of Assets
---0.910.394.89
Asset Writedown & Restructuring Costs
1.531.530.59---
Loss (Gain) From Sale of Investments
-2.2-2.2-1.871.42-2.48-1.51
Provision & Write-off of Bad Debts
5.15.18.363.082.460.86
Other Operating Activities
0.6331.820.6913.656.332.52
Change in Accounts Receivable
-79.14-79.14-49.969.82-22.22-17.6
Change in Inventory
-51.21-51.21-120.11-63.79-38.72-12.54
Change in Accounts Payable
57.3257.3283.0418.6457.6-5.28
Change in Other Net Operating Assets
2.82.84.212.851.121.11
Operating Cash Flow
190.86178.4525.2784.7895.6252.41
Operating Cash Flow Growth
225.79%606.07%-70.19%-11.34%82.44%-35.17%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-158.6-145.77-247.48-277.98-135.85-64.22
Sale of Property, Plant & Equipment
0.10.10.050.330.130.11
Divestitures
1.661.66----
Investment in Securities
29.81-46.9213.45-93.4152.3-209.9
Other Investing Activities
-110.430.533.151.754.38-7.9
Investing Cash Flow
-237.47-190.4-230.83-369.3120.96-281.91

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-437.91302.58216.710030
Total Debt Issued
567.5437.91302.58216.710030
Long-Term Debt Repaid
--430.66-82.29-57.94-30.93-1.93
Lease Payments
-17.63-17.63-0.93-0.93--
Total Debt Repaid
-451.9-430.66-82.29-57.94-30.93-1.93
Net Debt Issued (Repaid)
115.67.24220.29158.7569.0728.07
Issuance of Common Stock
--6.58--310
Common Dividends Paid
-76.14-36-34.17-29.18-26.82-0.03
Other Financing Activities
-58.1389.08-0.20.18--25.85
Financing Cash Flow
-18.6760.33192.51129.7542.25312.2

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.5-0.760.680.53-0.67
Net Cash Flow
-67.7847.61-12.37-154.27161.8382.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
32.2632.68-222.2-193.2-40.23-11.81
Free Cash Flow Growth
------
Free Cash Flow Margin
3.35%4.41%-48.72%-44.41%-10.17%-3.06%
Free Cash Flow Per Share
0.150.15-1.01-0.87-0.18-0.06
Levered Free Cash Flow
-106.38-65.08-239.08-252.24-83.39-50.55
Unlevered Free Cash Flow
-104.59-55.62-231.71-246.57-81.36-50.45
Free Cash Flow After Leases
14.6315.05-223.14-194.13-40.23-11.81

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
14.6711.4429.957.4217.5434.69
Change in Working Capital
-73.71-73.71-88.27-33.75-1.52-34.35